Related Experiment Video
Updated: Feb 4, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Regulatory mechanisms of incomplete huntingtin mRNA splicing
Andreas Neueder1,2, Anaelle A Dumas3, Agnesska C Benjamin3
1UCL Huntington's Disease Centre, Department of Neurodegenerative Disease and Dementia Research Institute, UCL Institute of Neurology, University College London, London, WC1N 3BG, UK. andreas.neueder@uni-ulm.de.
Insights
Incomplete splicing of the HTT gene produces a pathogenic protein in Huntington's disease. Splicing factor SRSF6 and transcription speed influence this aberrant splicing event.
Area of Science:
- Genetics
- Molecular Biology
- Neurodegenerative Diseases
Background:
- Huntington's disease (HD) results from CAG repeat expansion in the HTT gene.
- Aberrant splicing can produce a pathogenic HTT exon 1 protein (HTTexon1), but the mechanisms are unclear.
Purpose of the Study:
- To investigate the mechanisms underlying HTTexon1 production.
- To identify regulatory elements and factors involved in this splicing event.
Main Methods:
- Development of a minigene system to study HTT splicing.
- Analysis of intron 1 regions critical for incomplete splicing.
- Investigation of splicing factor SRSF6 and RNA polymerase II transcription speed.
Main Results:
- The minigene system recapitulated CAG repeat-length-dependent HTTexon1 production.
- Specific regions of intron 1 were identified as necessary for incomplete splicing.
- SRSF6 expression levels modulated HTTexon1 production, and transcription speed regulated its levels.
Conclusions:
- Splicing factor SRSF6 and RNA polymerase II transcription speed are key regulators of pathogenic HTTexon1 production.
- Understanding these mechanisms may lead to strategies for preventing HTT exon 1 protein generation in Huntington's disease.
Abstract:
Huntington's disease is caused by a CAG repeat expansion in exon 1 of the HTT gene. We have previously shown that exon 1 HTT does not always splice to exon 2 producing a small transcript (HTTexon1) that encodes the highly pathogenic exon 1 HTT protein. The mechanisms by which this incomplete splicing occurs are unknown. Here, we have generated a minigene system that recapitulates the CAG repeat-length dependence of HTTexon1 production, and has allowed us to define the regions of intron 1 necessary for incomplete splicing. We show that manipulation of the expression levels of the splicing factor SRSF6, predicted to bind CAG repeats, modulates this aberrant splicing event and also demonstrate that RNA polymerase II transcription speed regulates the levels of HTTexon1 production. Understanding the mechanisms by which this pathogenic exon 1 HTT is generated may provide the basis for the development of strategies to prevent its production.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nuclear Export of mRNA
Pre-mRNA Processing: RNA Splicing
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

